8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier

Mukut Sharma, Ellen T. McCarthy, D. Sudarshan Reddy, Paresh K. Patel, Virginia J. Savin, Meetha Medhora, John R. Falck

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Glomerular dysfunction and proteinuria characterize focal segmental glomerulosclerosis (FSGS) associated with chronic kidney disease. FSGS is resistant to treatment and a circulating permeability factor (FSPF) frequently causes post-renal transplantation recurrence. In order to explore the role of 5,6-, 8,9-, 11,12- and 14,15-epoxyeicosatrienoic acids (EETs), we determined their effect on FSPF-induced increase in glomerular albumin permeability (Palb) using an in vitro assay. Exogenous 8,9-EET (1-1000 nM) dose-dependently prevented the FSPF-induced increase in Palb. The other three EET regioisomers, 8,9-EET metabolite, 8,9-dihydroxyeicosatrienoic acid and unrelated 11,14-eicosadienoic acid (100 nM each) were not effective suggesting specificity of the observed glomerular protection by 8,9-EET. Synthetic analogs of 8,9-EET containing one double bond antagonized the effect of 8,9-EET on the FSPF-induced increase in Palb. Analogs containing two double bonds did not antagonize the effect of 8,9-EET and significantly blocked the FSPF-induced increase in Palb. These novel findings suggest a unique protective role for 8,9-EET in the glomerulus. Stable analogs of 8,9-EET may be valuable in developing effective management/treatment of glomerular dysfunction.

Original languageEnglish (US)
Pages (from-to)43-51
Number of pages9
JournalProstaglandins and Other Lipid Mediators
Volume89
Issue number1-2
DOIs
StatePublished - Jun 2009

Fingerprint

Glomerular Filtration Barrier
Focal Segmental Glomerulosclerosis
Permeability
Acids
8,9-epoxyeicosatrienoic acid
Metabolites
Chronic Renal Insufficiency
Proteinuria
Albumins
Assays
Kidney Transplantation

Keywords

  • 8,9-EET
  • Albumin permeability
  • Chronic kidney disease
  • Epoxyeicosatrienoic acids
  • FSGS
  • Glomerular filtration barrier

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier. / Sharma, Mukut; McCarthy, Ellen T.; Reddy, D. Sudarshan; Patel, Paresh K.; Savin, Virginia J.; Medhora, Meetha; Falck, John R.

In: Prostaglandins and Other Lipid Mediators, Vol. 89, No. 1-2, 06.2009, p. 43-51.

Research output: Contribution to journalArticle

Sharma, Mukut ; McCarthy, Ellen T. ; Reddy, D. Sudarshan ; Patel, Paresh K. ; Savin, Virginia J. ; Medhora, Meetha ; Falck, John R. / 8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier. In: Prostaglandins and Other Lipid Mediators. 2009 ; Vol. 89, No. 1-2. pp. 43-51.
@article{5cab4a3238994d7cbb4bfe8eae7e7f9f,
title = "8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier",
abstract = "Glomerular dysfunction and proteinuria characterize focal segmental glomerulosclerosis (FSGS) associated with chronic kidney disease. FSGS is resistant to treatment and a circulating permeability factor (FSPF) frequently causes post-renal transplantation recurrence. In order to explore the role of 5,6-, 8,9-, 11,12- and 14,15-epoxyeicosatrienoic acids (EETs), we determined their effect on FSPF-induced increase in glomerular albumin permeability (Palb) using an in vitro assay. Exogenous 8,9-EET (1-1000 nM) dose-dependently prevented the FSPF-induced increase in Palb. The other three EET regioisomers, 8,9-EET metabolite, 8,9-dihydroxyeicosatrienoic acid and unrelated 11,14-eicosadienoic acid (100 nM each) were not effective suggesting specificity of the observed glomerular protection by 8,9-EET. Synthetic analogs of 8,9-EET containing one double bond antagonized the effect of 8,9-EET on the FSPF-induced increase in Palb. Analogs containing two double bonds did not antagonize the effect of 8,9-EET and significantly blocked the FSPF-induced increase in Palb. These novel findings suggest a unique protective role for 8,9-EET in the glomerulus. Stable analogs of 8,9-EET may be valuable in developing effective management/treatment of glomerular dysfunction.",
keywords = "8,9-EET, Albumin permeability, Chronic kidney disease, Epoxyeicosatrienoic acids, FSGS, Glomerular filtration barrier",
author = "Mukut Sharma and McCarthy, {Ellen T.} and Reddy, {D. Sudarshan} and Patel, {Paresh K.} and Savin, {Virginia J.} and Meetha Medhora and Falck, {John R.}",
year = "2009",
month = "6",
doi = "10.1016/j.prostaglandins.2009.04.004",
language = "English (US)",
volume = "89",
pages = "43--51",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier BV",
number = "1-2",

}

TY - JOUR

T1 - 8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier

AU - Sharma, Mukut

AU - McCarthy, Ellen T.

AU - Reddy, D. Sudarshan

AU - Patel, Paresh K.

AU - Savin, Virginia J.

AU - Medhora, Meetha

AU - Falck, John R.

PY - 2009/6

Y1 - 2009/6

N2 - Glomerular dysfunction and proteinuria characterize focal segmental glomerulosclerosis (FSGS) associated with chronic kidney disease. FSGS is resistant to treatment and a circulating permeability factor (FSPF) frequently causes post-renal transplantation recurrence. In order to explore the role of 5,6-, 8,9-, 11,12- and 14,15-epoxyeicosatrienoic acids (EETs), we determined their effect on FSPF-induced increase in glomerular albumin permeability (Palb) using an in vitro assay. Exogenous 8,9-EET (1-1000 nM) dose-dependently prevented the FSPF-induced increase in Palb. The other three EET regioisomers, 8,9-EET metabolite, 8,9-dihydroxyeicosatrienoic acid and unrelated 11,14-eicosadienoic acid (100 nM each) were not effective suggesting specificity of the observed glomerular protection by 8,9-EET. Synthetic analogs of 8,9-EET containing one double bond antagonized the effect of 8,9-EET on the FSPF-induced increase in Palb. Analogs containing two double bonds did not antagonize the effect of 8,9-EET and significantly blocked the FSPF-induced increase in Palb. These novel findings suggest a unique protective role for 8,9-EET in the glomerulus. Stable analogs of 8,9-EET may be valuable in developing effective management/treatment of glomerular dysfunction.

AB - Glomerular dysfunction and proteinuria characterize focal segmental glomerulosclerosis (FSGS) associated with chronic kidney disease. FSGS is resistant to treatment and a circulating permeability factor (FSPF) frequently causes post-renal transplantation recurrence. In order to explore the role of 5,6-, 8,9-, 11,12- and 14,15-epoxyeicosatrienoic acids (EETs), we determined their effect on FSPF-induced increase in glomerular albumin permeability (Palb) using an in vitro assay. Exogenous 8,9-EET (1-1000 nM) dose-dependently prevented the FSPF-induced increase in Palb. The other three EET regioisomers, 8,9-EET metabolite, 8,9-dihydroxyeicosatrienoic acid and unrelated 11,14-eicosadienoic acid (100 nM each) were not effective suggesting specificity of the observed glomerular protection by 8,9-EET. Synthetic analogs of 8,9-EET containing one double bond antagonized the effect of 8,9-EET on the FSPF-induced increase in Palb. Analogs containing two double bonds did not antagonize the effect of 8,9-EET and significantly blocked the FSPF-induced increase in Palb. These novel findings suggest a unique protective role for 8,9-EET in the glomerulus. Stable analogs of 8,9-EET may be valuable in developing effective management/treatment of glomerular dysfunction.

KW - 8,9-EET

KW - Albumin permeability

KW - Chronic kidney disease

KW - Epoxyeicosatrienoic acids

KW - FSGS

KW - Glomerular filtration barrier

UR - http://www.scopus.com/inward/record.url?scp=65649089846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649089846&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2009.04.004

DO - 10.1016/j.prostaglandins.2009.04.004

M3 - Article

VL - 89

SP - 43

EP - 51

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 1-2

ER -